Related Experiment Video
Updated: May 31, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Treatment strategies in acute myeloid leukemia
Li-na Han1, Jin Zhou, Jan Jacob Schuringa
1Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Objective:
To summarize the risk stratification and current treatment strategies for acute myeloid leukemia (AML) and discuss the role of emerging novel agents that might be applied in future clinical trials.
Data Sources:
The data in this article were collected from PubMed database with relevant English articles published from 1991 to 2009.
Study Selection:
Articles regarding the risk stratification and therapeutic options of AML, as well as the characteristics of leukemic stem cells were selected.
Results:
AML is a heterogeneous disease with variable clinical outcome dependent on several prognostic factors, including age, cytogenetics and molecular markers. The advances in the understanding of AML pathogenesis and development will generate potential novel agents that might improve the treatment results of standard chemotherapy.
Conclusion:
Deeper insight into the multiple transforming events of AML may aid us in designing combinations of small molecule inhibitors based on the individual patient characteristics.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Pharmaceutical Poisoning: Treatment Strategies
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Differentiation of Common Myeloid Progenitor Cells
